Core Capabilities &Approach: NMR screening will be carried out by 2-D ^SN-^H HSQC spectroscopy. Initial NMR spectra will be recorded at 20?C on uniformly [15]N-labeled proteins. The proteins will be categorized into one of four groups based on the HSQC spectral dispersion and HetNOE data: """"""""good"""""""", """"""""promising"""""""", """"""""poor"""""""", or """"""""unfolded"""""""". This information will be fed back to the Protein Core for iterative improvement of constructs, etc. HSQC spectra will be used to screen putative interactions with cellular host proteins. If necessary, screening will be carried out on dilute samples (~10(uM) and using 3 mm NMR tubes (150uml). Any spectral changes that occur upon addition of possible binding proteins (unlabeled) will be monitored. Three scenarios are possible: 1) resonances may shift gradually in position upon addition of a binding partner, indicating that binding is weak (Kd>10uM). In this case, the structure of the complex can be determined with an excess of binding partner, after shifting the equilibrium to saturation(243-245);2) HSQC resonances may broaden or disappear due to exchange on the microsecond-millisecond timescale or due to the large size of the complex. In this case, experimental conditions, such as temperature, salts, and buffers will be changed, or 2H,i5N-labeled samples prepared. Samples of this kind will enter the crystallization pipleline;3) new resonances are observed in the HSQC spectrum. In this case, addition of successive aliquots of the binding protein will result in an increase in peak intensity for the new resonances with a concomitant decrease and disappearance of the free original resonances (slow exchange regime), indicative of tight binding (Kd<~1uM). For these cases, Kas will be determined and structure determination will be pursued. NMR structure determination: We will prepare mixed NMR samples containing one component labeled with 3C/15N and the other component unlabeled(13). Total [1]H/[13]C/[15]N NMR assignments will be obtained using 3-D HNCACB, HNCA, HN(CO)CACB, HN(CO)CA, H(CCO)NH-TOCSY, C(CO)HN-TOCSY and HCCH-TOCSY experiments and standard protocols(246-251), the final structures will be calculated using CYANA and XPLOR-NIH(252,253) incorporating all NOE distance, dihedral angle and RDC constraints. iii. Project Component: In addition to screening activities, the NMR Core will be involved in P1 (structures of CA), P4 (conformational dynamics of RT), P5 (DCAF1 domains), and P6 (APOBEC family proteins).

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Specialized Center (P50)
Project #
5P50GM082251-07
Application #
8546400
Study Section
Special Emphasis Panel (ZRG1-AARR-K)
Project Start
Project End
Budget Start
2013-09-01
Budget End
2014-08-31
Support Year
7
Fiscal Year
2013
Total Cost
$249,068
Indirect Cost
$67,609
Name
University of Pittsburgh
Department
Type
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Gupta, Rupal; Lu, Manman; Hou, Guangjin et al. (2016) Dynamic Nuclear Polarization Enhanced MAS NMR Spectroscopy for Structural Analysis of HIV-1 Protein Assemblies. J Phys Chem B 120:329-39
Van Oss, S Branden; Shirra, Margaret K; Bataille, Alain R et al. (2016) The Histone Modification Domain of Paf1 Complex Subunit Rtf1 Directly Stimulates H2B Ubiquitylation through an Interaction with Rad6. Mol Cell 64:815-825
Perilla, Juan R; Gronenborn, Angela M (2016) Molecular Architecture of the Retroviral Capsid. Trends Biochem Sci 41:410-20
Sharaf, Naima G; Ishima, Rieko; Gronenborn, Angela M (2016) Conformational Plasticity of the NNRTI-Binding Pocket in HIV-1 Reverse Transcriptase: A Fluorine Nuclear Magnetic Resonance Study. Biochemistry 55:3864-73
Byeon, In-Ja L; Byeon, Chang-Hyeock; Wu, Tiyun et al. (2016) Nuclear Magnetic Resonance Structure of the APOBEC3B Catalytic Domain: Structural Basis for Substrate Binding and DNA Deaminase Activity. Biochemistry 55:2944-59
Saito, Akatsuki; Ferhadian, Damien; Sowd, Gregory A et al. (2016) Roles of Capsid-Interacting Host Factors in Multimodal Inhibition of HIV-1 by PF74. J Virol 90:5808-23
Ning, Jiying; Erdemci-Tandogan, Gonca; Yufenyuy, Ernest L et al. (2016) In vitro protease cleavage and computer simulations reveal the HIV-1 capsid maturation pathway. Nat Commun 7:13689
Rasheedi, Sheeba; Shun, Ming-Chieh; Serrao, Erik et al. (2016) The Cleavage and Polyadenylation Specificity Factor 6 (CPSF6) Subunit of the Capsid-recruited Pre-messenger RNA Cleavage Factor I (CFIm) Complex Mediates HIV-1 Integration into Genes. J Biol Chem 291:11809-19
Ramalho, Ruben; Rankovic, Sanela; Zhou, Jing et al. (2016) Analysis of the mechanical properties of wild type and hyperstable mutants of the HIV-1 capsid. Retrovirology 13:17
Oum, Yoon Hyeun; Desai, Tanay M; Marin, Mariana et al. (2016) Click labeling of unnatural sugars metabolically incorporated into viral envelope glycoproteins enables visualization of single particle fusion. J Virol Methods 233:62-71

Showing the most recent 10 out of 113 publications